A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease.

By Walter J. Lukiw, J. Cui, V. Marcheselli, Merete Bodker, Anja Botkjaer, K. Gotlinger, C. Serhan, N. Bazan. Journal of Clinical Investigation, 2005

872 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Mammalian lipoxygenases and their biological relevance (2014, background): “patients [345] and this effect was paralleled by reduced neuroprotectin D1 levels.”
Micro-RNA speciation in fetal, adult and Alzheimer's disease hippocampus (2007, background): “Unless mRNAs are stabilized by extrinsic factors, such as mRNAbinding proteins, antiribonuclease proteins and neutral pH, they are intrinsically unstable, rapidly degraded, information-rich molecules associated with the cytoplasmic RNA granule complex [13,14,20].”
Essential fatty acids: biochemistry, physiology and pathology (2006, background): “Both LXs and NPD1 enhanced wound healing [95], and promoted brain cell survival via the induction of anti-apoptotic and neuroprotective gene-expression programs that suppress Aβ42-induced neurotoxicity [77, 78].”
Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators (2008, neutral): “and neural systems that has been documented in studies by Bazan and colleague”